A new kind of intelligence is flowing through the pharmaceutical supply chain. An intelligence that goes beyond data processing or time optimization—it challenges established models, rewrites decision-making maps, and opens paths into previously unthinkable territories. It is artificial intelligence, of course, but also a collective intelligence that emerges from the intersection of technology, industry, research, and regulatory culture. At SPS Italia 2025, this convergence takes tangible form in the round table AI & Pharma Revolution, organized by MakingLife: a unique opportunity to share experiences and visions in a sector that can afford neither delays nor improvisation.
This special issue dedicated to SPS Italia 2025 accompanies the reflection with articles, interviews, and insights on the impact of automation and AI on pharmaceutical production. We are not just talking about technological innovation, but about systemic transformation: from the digitalization of batch records to data governance in GxP environments, from IIoT platform integration to sustainability as a key design principle.
SPS Italia confirms its role as a dynamic lab of ideas and best practices, with the pharmaceutical industry playing a strategic role. This tabloid aims to be part of that conversation—because, in the end, even the most digital of revolutions needs the right words to be understood.